Acta Scientific Cancer Biology

Mini ReviewVolume 1 Issue 2

Oncolytic Potential of Tanapoxvirus for the Treatment of Melanoma

Tiantian Zhang and Karim Essani*

Laboratory of Virology, Department of Biological Sciences, Western Michigan University, Kalamazoo, USA

*Corresponding Author: Karim Essani, Laboratory of Virology, Department of Biological Sciences, Western Michigan University, Kalamazoo, USA.

Received: June 04, 2017; Published: September 25, 2017

Citation: Tiantian Zhang and Karim Essani. “Oncolytic Potential of Tanapoxvirus for the Treatment of Melanoma”. Acta Scientific Cancer Biology 1.2 (2018).


  Melanoma is the deadliest skin cancer with significant morbidity and mortality. Oncolytic viruses (OVs), which are naturally occurring or genetically engineered viruses, have emerged as a class of novel therapeutic agents for melanoma treatment. At the confluence of virology, immunology and genetic engineering, OVs have been designed and optimized into anti-cancer agents using versatile strategies.

  Tanapoxvirus (TPV), which possesses a large genome and causes only mild self-limiting diseases, appears as an ideal OV candi- date. Here, we provide a summary of applying engineered TPVs as experimental melanoma immuno-virotherapy in our work, emphasizing the successful strategies used to achieve increased onco-specificity, oncolysis and immuno-reactivity.

Keywords: Tanapoxvirus, Oncolytic virotherapy, Melanoma, Interleukin-2, Neuregulin, Matrix metalloproteinase

Copyright: © 2018 Tiantian Zhang and Karim Essani. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Member In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 25, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US